Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: a population-level study

medRxiv(2022)10.1101/2022.04.08.22273571Source: DataRank Database

Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: a population-level study is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0.125. It has been cited 1 time, with 1 citing works in its 1-hop citation network.

N/A

0.125DataRank · unranked

Scored on demand from live citation data

Open Access1 citations · 1 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)OA: greenTopics (21)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 83%Citation Network 17%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

0.0209

From 1 citing papers with measurable signal

Learn more about DataRank methodology →

Top 1 citer driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 1 citer.

SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil
Scientific Reports20235 citations73 referencesContributes 0.025

Authors (11)

Cleo Anastassopoulou ORCID,Zagorka Lozanov-Crvenković ORCID,Vladimir Vuković ORCID,Nataša Dragnić ORCID,Vladimir Petrović ORCID

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4223981084

Ministry of Education, Science and Technological Development of Republic of Serbia

Grant: 200125

Ministry of Education, Science and Technological Development, Republic of Serbia, Grant no. 451-03-68/2020-14/200125 (University of Novi Sad, Faculty of Science)

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/04/22/2022.04.08.22273571.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.04.08.22273571

repositoryhttps://doi.org/10.1101/2022.04.08.22273571

Fields of Study

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies03 medical and health sciences0302 clinical medicine

Keywords

MedicineCase fatality rateIncidence (geometry)Retrospective cohort studyPediatricsVaccinationCohort studyCoronavirus disease 2019 (COVID-19)CohortPopulationInternal medicineEpidemiologyVirologyEnvironmental healthInfectious disease (medical specialty)Disease

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being